These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 17522621)
1. No association of ERCC1 C8092A and T19007C polymorphisms to cancer risk: a meta-analysis. Li Y; Gu S; Wu Q; Li Y; Fu X; Mao Y; Huang Y; Xie Y Eur J Hum Genet; 2007 Sep; 15(9):967-73. PubMed ID: 17522621 [TBL] [Abstract][Full Text] [Related]
2. Gene-smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer. Zhou W; Liu G; Park S; Wang Z; Wain JC; Lynch TJ; Su L; Christiani DC Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):491-6. PubMed ID: 15734977 [TBL] [Abstract][Full Text] [Related]
3. Association of ERCC1-C118T and -C8092A polymorphisms with lung cancer risk and survival of advanced-stage non-small cell lung cancer patients receiving platinum-based chemotherapy: a pooled analysis based on 39 reports. Xu TP; Shen H; Liu LX; Shu YQ Gene; 2013 Sep; 526(2):265-74. PubMed ID: 23727606 [TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in ERCC1 and grade 3 or 4 toxicity in non-small cell lung cancer patients. Suk R; Gurubhagavatula S; Park S; Zhou W; Su L; Lynch TJ; Wain JC; Neuberg D; Liu G; Christiani DC Clin Cancer Res; 2005 Feb; 11(4):1534-8. PubMed ID: 15746057 [TBL] [Abstract][Full Text] [Related]
5. Lack of association between DNA repair gene ERCC1 polymorphism and risk of lung cancer in a Chinese population. Yin J; Vogel U; Guo L; Ma Y; Wang H Cancer Genet Cytogenet; 2006 Jan; 164(1):66-70. PubMed ID: 16364765 [TBL] [Abstract][Full Text] [Related]
6. A meta-analysis on XRCC1 R399Q and R194W polymorphisms, smoking and bladder cancer risk. Lao T; Gu W; Huang Q Mutagenesis; 2008 Nov; 23(6):523-32. PubMed ID: 18765423 [TBL] [Abstract][Full Text] [Related]
7. DNA repair gene XRCC3 polymorphisms and cancer risk: a meta-analysis of 48 case-control studies. Han S; Zhang HT; Wang Z; Xie Y; Tang R; Mao Y; Li Y Eur J Hum Genet; 2006 Oct; 14(10):1136-44. PubMed ID: 16791138 [TBL] [Abstract][Full Text] [Related]
8. Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. Zhou W; Gurubhagavatula S; Liu G; Park S; Neuberg DS; Wain JC; Lynch TJ; Su L; Christiani DC Clin Cancer Res; 2004 Aug; 10(15):4939-43. PubMed ID: 15297394 [TBL] [Abstract][Full Text] [Related]
9. Characterization of functional excision repair cross-complementation group 1 variants and their association with lung cancer risk and prognosis. Yu D; Zhang X; Liu J; Yuan P; Tan W; Guo Y; Sun T; Zhao D; Yang M; Liu J; Xu B; Lin D Clin Cancer Res; 2008 May; 14(9):2878-86. PubMed ID: 18451256 [TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in ERCC1 and susceptibility to childhood acute lymphoblastic leukemia in a Chinese population. Wang SL; Zhao H; Zhou B; Chen YL; Zou Y; Zhu XF; Li QS; Han MZ; Yang RC; Han ZC Leuk Res; 2006 Nov; 30(11):1341-5. PubMed ID: 16723154 [TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of ERCC1 C118T/C8092A and MDR1 C3435T predict outcome of platinum-based chemotherapies in advanced non-small cell lung cancer: a meta-analysis. Wei HB; Lu XS; Shang LH; Xu G; Hu J; Che DH; Liu F; Wu Y; Zhang GM; Yu Y Arch Med Res; 2011 Jul; 42(5):412-20. PubMed ID: 21827803 [TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer. Moreno V; Gemignani F; Landi S; Gioia-Patricola L; Chabrier A; Blanco I; González S; Guino E; Capellà G; Canzian F Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2101-8. PubMed ID: 16609022 [TBL] [Abstract][Full Text] [Related]
13. The determination of relationship between "excision repair cross-complementing group 1" (ERCC1) gene T19007C and C8092A single nucleotide polymorphisms and clinicopathological parameters in non-small cell lung cancer. Koç E; Caner V; Büyükpınarbaşılı N; Tepeli E; Türk NS; Ozan Çetin G; Bağcı G Mol Biol Rep; 2012 Jan; 39(1):375-80. PubMed ID: 21553053 [TBL] [Abstract][Full Text] [Related]
14. Effects of ERCC1 expression in peripheral blood on the risk of head and neck cancer. Yang M; Kim WH; Choi Y; Lee SH; Kim KR; Lee HS; Tae K Eur J Cancer Prev; 2006 Jun; 15(3):269-73. PubMed ID: 16679872 [TBL] [Abstract][Full Text] [Related]
15. XRCC1 polymorphism and lung cancer risk. Schneider J; Classen V; Helmig S Expert Rev Mol Diagn; 2008 Nov; 8(6):761-80. PubMed ID: 18999926 [TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of DNA repair genes: ERCC1 G19007A and ERCC2/XPD C22541A in a northeastern Chinese population. Yin J; Li J; Vogel U; Wang H Biochem Genet; 2005 Oct; 43(9-10):543-8. PubMed ID: 16341770 [TBL] [Abstract][Full Text] [Related]
17. Associations between XPC polymorphisms and risk of cancers: A meta-analysis. Qiu L; Wang Z; Shi X; Wang Z Eur J Cancer; 2008 Oct; 44(15):2241-53. PubMed ID: 18771913 [TBL] [Abstract][Full Text] [Related]
18. The C19007T polymorphism of ERCC1 and its correlation with the risk of epithelial ovarian and endometrial cancer in Korean women. A case control study. Jo H; Kang S; Kim SI; Kim JW; Park NH; Song YS; Park SY; Kang SB; Lee HP Gynecol Obstet Invest; 2007; 64(2):84-8. PubMed ID: 17314486 [TBL] [Abstract][Full Text] [Related]
19. Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures. Saadat M; Ansari-Lari M Breast Cancer Res Treat; 2009 May; 115(1):137-44. PubMed ID: 18481169 [TBL] [Abstract][Full Text] [Related]
20. Association of an ERCC1 polymorphism with adult-onset glioma. Chen P; Wiencke J; Aldape K; Kesler-Diaz A; Miike R; Kelsey K; Lee M; Liu J; Wrensch M Cancer Epidemiol Biomarkers Prev; 2000 Aug; 9(8):843-7. PubMed ID: 10952103 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]